Mcp and Jardiance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mcp (pectin) and Jardiance (empagliflozin). Common drug interactions include haematoma infection among females and cardiovascular disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Mcp and Jardiance. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Mcp?

Mcp has active ingredients of pectin. eHealthMe is studying from 2,077 Mcp users. Check the latest studies of Mcp.

What is Jardiance?

Jardiance has active ingredients of empagliflozin. It is often used in hyperglycemia. eHealthMe is studying from 44,457 Jardiance users. Check the latest studies of Jardiance.



On Jul, 11, 2026

16 people who take Mcp and Jardiance together, and have interactions are studied.

Mcp and Jardiance drug interactions.

What are the common drug interactions of Mcp and Jardiance, by gender? *:

female:

  1. Haematoma infection (infection with collection of blood outside the blood vessels)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Renal abscess (pus in kidney)
  4. Retroperitoneal haematoma (blood clot between the peritoneum and the posterior abdominal wall)

male:

  1. Cardiovascular disorder (heart diseases)
  2. Depression
  3. Fatigue (feeling of tiredness)
  4. General physical health deterioration (weak health status)
  5. Ill-defined disorder
  6. Joint effusion (presence of extra fluid in joint covering)
  7. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  8. Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle)
  9. Synovial cyst (cyst of joint filled with synovial fluid)
  10. Anxiety disorder

What are the common drug interactions of Mcp and Jardiance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Haematoma infection (infection with collection of blood outside the blood vessels)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Renal abscess (pus in kidney)
  4. Retroperitoneal haematoma (blood clot between the peritoneum and the posterior abdominal wall)

50-59:

n/a

60+:

  1. Lower limb fracture

What are the existing conditions these people have? *

  1. High Blood Pressure: 12 people, 75.00%
  2. Type 2 Diabetes: 11 people, 68.75%
  3. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 18.75%
  4. Rickets (softening of bones): 2 people, 12.50%
  5. Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 12.50%
  6. Pain: 2 people, 12.50%
  7. Nausea (feeling of having an urge to vomit): 2 people, 12.50%
  8. Insomnia (sleeplessness): 2 people, 12.50%
  9. Asthma: 2 people, 12.50%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Mcp and Jardiance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mcp and Jardiance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mcp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Jardiance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mcp and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Jardiance and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pectin and empagliflozin (the active ingredients of Mcp and Jardiance, respectively), and Mcp and Jardiance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: